1	Iniciar	iniciar	VMN0000	-	-	0-7	144(1)_ANS_clinical_caseMIR	SENT1	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#r√©gimen/tratamiento	8-19	144(1)_ANS_clinical_caseMIR	SENT1	-	-
3	con	con	SPS00	C0332287	atributo	20-23	144(1)_ANS_clinical_caseMIR	SENT1	-	-
4	isoniacida	isoniacida	NC00SC0	C0022209	producto	24-34	144(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
5	,	,	Fc	-	-	34-35	144(1)_ANS_clinical_caseMIR	SENT1	-	-
6	rifampicina	rifampicina	NCFS000	C0035608	sustancia	36-47	144(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
7	.	.	Fp	-	-	47-48	144(1)_ANS_clinical_caseMIR	SENT1	-	-
8	pirazinamida	pirazinamida	NC00SC0	C0034239	sustancia	49-61	144(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
9	y	y	CC	C1706368	calificador	62-63	144(1)_ANS_clinical_caseMIR	SENT1	-	-
10	etambutol	etambutol	NC00SC0	C0014964	sustancia	64-73	144(1)_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
11	.	.	Fp	-	-	73-74	144(1)_ANS_clinical_caseMIR	SENT1	-	-

